MYC and hepatocellular carcinoma: IFITM3 enhanced the invasion and metastasis of hepatocellular carcinoma through regulating expression of MMP9 via the p38/MAPK pathway and promoted proliferation of hepatocellular carcinoma via regulating expression of c-myc through the ERK1/2 signaling pathway (19, 20).